Cargando…
Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis
BACKGROUND: This review’s goals were to investigate apremilast’s efficacy versus placebo in palmoplantar psoriasis (PP) and palmoplantar pustulosis (PPP), and apremilast’s efficacy versus methotrexate in PP. METHODS: A literature search was conducted in PubMed, clinicaltrials.gov, and Embase in July...
Autores principales: | Spencer, Riley K., Elhage, Kareem G., Jin, Joy Q., Davis, Mitchell S., Hakimi, Marwa, Bhutani, Tina, Liao, Wilson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884725/ https://www.ncbi.nlm.nih.gov/pubmed/36609960 http://dx.doi.org/10.1007/s13555-022-00877-w |
Ejemplares similares
-
Apremilast monotherapy for palmoplantar pustulosis: Report of three cases
por: Marovt, Maruška, et al.
Publicado: (2021) -
The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review
por: Sanchez, Isabelle M., et al.
Publicado: (2017) -
Immediate response to apremilast in patients with palmoplantar pustulosis: a retrospective pilot study
por: Kato, Noriko, et al.
Publicado: (2021) -
Interleukin-19 Levels Are Increased in Palmoplantar Pustulosis and Reduced following Apremilast Treatment
por: Wolk, Kerstin, et al.
Publicado: (2023) -
Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
por: Kim, Tae Hyung, et al.
Publicado: (2022)